Nospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University.
We aim to deliver novel and effective therapeutics as quickly as possible to make a lasting difference in the lives of millions of patients and their caring families.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Montreal, Quebec, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.nospharma.ca
- Keywords
- IT Consulting.
- HQ
- Montreal, Quebec
Nospharma Questions
Nospharma's website is http://www.nospharma.ca
Nospharma's LinkedIn profile is https://www.linkedin.com/company/nospharma
Nospharma has
3 employees.
View email and phone details for 3
employees at Nospharma.
Nospharma's industry is
Biotechnology Research
Nospharma's top competitors are
Laurent Pharmaceuticals,
Inversago Pharma,
Lyfgen,
Congruence Therapeutics,
Cura Therapeutics Inc.,
Bioquebec,
Kli Capital,
Giiant Pharma Inc.,
Modulari-T Bio,
District 3 Innovation.
Nospharma's categories are Biotechnology Research
Nospharma's founding year is 2022
